Prognostic value of pneumococcal urinary antigen test in community-acquired pneumonia

PLoS One. 2018 Jul 20;13(7):e0200620. doi: 10.1371/journal.pone.0200620. eCollection 2018.

Abstract

Background: The pneumococcal urinary antigen test (UAT) has been known to improve sensitivity and specificity for the diagnosis of pneumococcal pneumonia. Associations of UAT results with prognosis in community acquired pneumonia (CAP) are not known. We hypothesized that positive UAT is associated with a good prognosis, and incorporation of UAT into CRB65 would improve its prognostic performance.

Methods: In this registry-based retrospective study, we analyzed CAP patients over a 10-year period beginning in April 2008. Patients who had UAT results were included in multivariable extended Cox-regression analyses to determine the association between UAT positivity and 30-day mortality. UAT results were incorporated for patients with a CRB65 score of 1 by subtracting 1 from the scoring system if the test was positive. The performance of the modified scoring systems was assessed with area under the receiver operating characteristic (AUROC) curves.

Results: Among 5145 CAP patients, total 2280 patients had UAT results and were included in analyses. A positive UAT result was associated with a good prognosis after a week of hospitalization (aHR, 0.14; p = 0.007). After modification of CRB65 using UAT results, positive and negative predictive values for 30-day mortality were increased from 7.7 to 8.3 (p<0.001) and 98.9 to 99.1 (p = 0.010). The AUROC increased from 0.73 to 0.75 (p<0.001).

Conclusions: Positive results on UAT could be considered as a good prognostic factor in CAP. UAT could be used as a useful tool in deciding whether to refer patients to the hospital, especially in moderate CAP with a CRB score of 1.

Publication types

  • Evaluation Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antigens, Bacterial / urine*
  • Community-Acquired Infections / diagnosis
  • Community-Acquired Infections / microbiology
  • Community-Acquired Infections / mortality*
  • Community-Acquired Infections / urine
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pneumonia, Pneumococcal / diagnosis
  • Pneumonia, Pneumococcal / microbiology
  • Pneumonia, Pneumococcal / mortality*
  • Pneumonia, Pneumococcal / urine
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • ROC Curve
  • Republic of Korea / epidemiology
  • Retrospective Studies
  • Streptococcus pneumoniae / immunology
  • Streptococcus pneumoniae / isolation & purification*
  • Survival Rate

Substances

  • Antigens, Bacterial

Grants and funding

The author(s) received no specific funding for this work.